A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)
Clinical trial NCT02279875 · COMPLETED
Trial details
- NCT number
- NCT02279875
- Sponsor
- Global Alliance for TB Drug Development
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-11-28
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.